drugset / Trial / NCT00006877
Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer
Phase 2
Completed
30 enrolled
Case Comprehensive Cancer Center
National Cancer Institute (NCI) · collabSchering-Plough · collab
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients who have metastatic non-small cell lung cancer.
Timeline
- Start
- 2000-07
- Primary completion
- 2003-09
- Completion
- 2003-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temozolomide | Small molecule | — | Oral |